APPROVAL OF NIH RESEARCH PROJECT ENTITLED "TARGETED

UNCLAS BRASILIA 002458

SIPDIS

SIPDIS

STATE PASS TO DHHS/NIH/FIC FOR KEVIN BIALY

E.O. 12958: N/A
TAGS: TBIO KSCA OSCI BR
SUBJECT: APPROVAL OF NIH RESEARCH PROJECT ENTITLED "TARGETED
THERAPHY FOR BURKITT LYMPHOMA IN RESOURCE POOR SETTING"

REF: BRASILIA 1880


1. On November 16, 2006, Embassy received from the Brazilian
Ministry of Foreign Affairs, Division of Science and Technology
(DCTEC/MFA) an official notification (number 56, dated November 16,
2006) approving the research project proposal titled "Targeted
Therapy for Burkitt Lymphoma in Resource Poor Settings", (number CA
121935-01),under the direction of Dr. Carlos Brites Alves, Dr. Jose
Henrique Silva Barreto, Dr. Iguaracyra Barreto de Oliveira Araujo,
from the Federal University of Bahia. Informal translation of the
approval notice follows:

Begin text:

"This is to inform that after consultation to the appropriate
federal organs, the project titled "Targeted Therapy for Burkitt
Lymphoma in Resource Poor Settings," to be developed by the
principal investigator Dr. Carlos Roberto Brites Alves, from the
Universidade Federal da Bahia (UFBA),Dr. Jose Henrique Silva
Barreto and Dr. Iguaracyra Barreto de Oliveira Araujo, these last
two only considered as investigators, financially supported by the
National Institutes of Health (NIH),was approved by the Brazilian
Government.

2) I emphasize that for the collection and transfer of data and/or
biological material abroad, procedures should conform to current
legislation.

Cordially,
(signature)
Everton Frask Lucero
Head of the Division of Science and Technology"

End of text of translation.


2. The Embassy sees no adverse foreign policy implications with
respect to this research project. We reiterate the importance of
complying with Brazilian law on the export of data and biological
material and medical research involving human beings.

CHICOLA